US Patent Issued to Kelonia Therapeutics on Oct. 7 for "Antigen binding polypeptides" (Massachusetts, New Hampshire, District Of Columbia Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,140, issued on Oct. 7, was assigned to Kelonia Therapeutics Inc. (Boston).

"Antigen binding polypeptides" was invented by Kevin M. Friedman (Boston), Molly R. Perkins (Milton, Mass.), Connor S. Dobson (Washington), Stephen L. Sazinsky (Winchester, Mass.), Shannon G. Contrastano (Auburndale, Mass.), Emily Thompson Beura (Mansfield, Mass.), Cory Ahonen (Lebanon, N.H.) and Andrew Avery (Lebanon, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions comprising antigen binding polypeptides. More particularly, the disclosure relates to polypeptides comprising antibodies or antigen binding fragments thereof, nuclei...